18269-Ovarian Cancer-NA-1244

Ovarian Cancer

ENGOT-ov50 / INNOVATE-3: Pivotal, Randomized, Open-Label Study ofTumor Treating Fields (TTFields, 200kHz) Concomitant with WeeklyPaclitaxel for the Treatment of Recurrent Ovarian Cancer

  • Details

ClinicalTrials.gov ID: NCT03940196
Diagnosis Type: NA
USOR Number:

  • Address

2312 N Nevada Ave, Suite 400
Colorado Springs, CO 80907
P: (719) 577-2555

Search by practice name, trial titles, indicators and specific disease types.